Holdings of Omega Fund Management, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 8 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Bicara Therapeutics Inc | 2,392,150 | 47.6M $ | |
| 2 | Nuvation Bio Inc | 8,081,089 | 34.7M $ | |
| 3 | BridgeBio Oncology Therapeutics Inc | 3,289,661 | 29.4M $ | |
| 4 | Beta Bionics Inc | 1,316,183 | 13.2M $ | |
| 5 | Alumis Inc | 241,255 | 5.3M $ | |
| 6 | Sana Biotechnology Inc | 843,750 | 2.4M $ | |
| 7 | IMAGENEBIO INC | 455,361 | 2.3M $ | |
| 8 | Replimune Group Inc | 248,672 | 1.9M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 8 | 136.8M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Omega Fund Management, LLC". https://titelia.com/en/funds/US13F1637359